Search bioRxiv⌕ Search

Biology subjects

Brinkman, A. B.

Publications and source records attributed to Brinkman, A. B..

2 recordsLinked to original sources

Methylome profiling of SetDB1 deficient ESCs reveals diverse epigenetic cross-talk during pluripotency

SetDB1 is best known as a chromatin modifier catalyzing H3K9me3. However, recent studies show that SetDB1 can promote H3K27me3-deposition and CTCF-binding, and potentially recruit de novo DNA methyltransferases. Given the tight connection with these processes, we hypothesized that DNA methylation (DNAme) may integrate these combined features of SetDB1. Thereto, we conducted time-course whole-genome bisulfite sequencing following Setdb1 knockout (KO) in mouse embryonic stem cells (ESCs). In serum-cultured ESCs, nearly half of SetDB1 binding sites are DNA methylated, coinciding with H3K9me3, mainly silencing retrotransposons and imprinting control regions. Both H3K9me3 and DNAme are lost upon Setdb1 KO, but while TET2 rapidly removes DNAme at many of these sites, some retrotransposons are shielded from TET2 and lose DNAme slowly via passive dilution. SetDB1-mediated regulation via H3K27me3, CTCF, SMAD3, and histone acetylation are uncoupled from the DNAme-H3K9me3 axis. Hypomethylated naive ESCs show massive reactivation of retrotransposons upon Setdb1 KO, providing functional evidence that DNAme adds a protective layer against such activity. Altogether, our findings reveal how DNAme coordinates the multifaceted regulatory roles of SetDB1. HighlightsO_LIIn serum ESCs, SetDB1-dependent deposition of H3K9me3 and DNAme are tightly coupled, primarily silencing repeats and imprinted control regions; C_LIO_LILoss of SetDB1 causes demethylation of a large range of repeat types, the pace of which is dependent on TET pre-loading; C_LIO_LIThe regulatory modes of SetDB1 mediated by H3K27me3, CTCF, TGF-{beta} signalling and histone acetylation are uncoupled from the SetDB1 DNAme-H3K9me3 axis and/or from each other; C_LIO_LILoss of SetDB1-dependent DNAme in hypomethylated 2i ESCs reveals that DNAme serves as a buffering layer to repress SetDB1-mediated H3K9me3 targets. C_LI

molecular biology↗

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation

Global loss of DNA methylation and CpG island (CGI) hypermethylation are regarded as key epigenomic aberrations in cancer. Global loss manifests itself in partially methylated domains (PMDs) which can extend up to megabases. However, the distribution of PMDs within and between tumor types, and their effects on key functional genomic elements including CGIs are poorly defined. Using whole genome bisulfite sequencing (WGBS) of breast cancers, we comprehensively show that loss of methylation in PMDs occurs in a large fraction of the genome and represents the prime source of variation in DNA methylation. PMDs are hypervariable in methylation level, size and distribution, and display elevated mutation rates. They impose intermediate DNA methylation levels incognizant of functional genomic elements including CGIs, underpinning a CGI methylator phenotype (CIMP). However, significant repression effects on cancer-genes are negligible as tumor suppressor genes are generally excluded from PMDs. The genomic distribution of PMDs reports tissue-of-origin of different cancers and may represent tissue-specific silent regions of the genome, which tolerate instability at the epigenetic, transcriptomic and genetic level.

cancer biology↗